|
1
|
Yang JD and Roberts LR: Epidemiology and
management of hepatocellular carcinoma. Infect Dis Clin North Am.
24:899–919. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duan XY, Zhang L, Fan JG and Qiao L: NAFLD
leads to liver cancer: Do we have sufficient evidence? Cancer Lett.
345:230–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karagozian R, Derdák Z and Baffy G:
Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism.
63:607–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakagawa H, Umemura A, Taniguchi K,
Font-Burgada J, Dhar D, Ogata H, Zhong Z, Valasek MA, Seki E,
Hidalgo J, et al: ER stress cooperates with hypernutrition to
trigger TNF-dependent spontaneous HCC development. Cancer Cell.
26:331–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang DY and Friedman SL:
Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology.
56:769–775. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He G and Karin M: NF-κB and STAT3 - key
players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siomi H and Siomi MC: On the road to
reading the RNA-interference code. Nature. 457:396–404. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Panera N, Gnani D, Crudele A, Ceccarelli
S, Nobili V and Alisi A: MicroRNAs as controlled systems and
controllers in non-alcoholic fatty liver disease. World J
Gastroenterol. 20:15079–15086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36(Database): D154–D158. Nov 8–2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoo BK, Emdad L, Su ZZ, Villanueva A,
Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet
JM, et al: Astrocyte elevated gene-1 regulates hepatocellular
carcinoma development and progression. J Clin Invest. 119:465–477.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vigouroux C, Auclair M, Dubosclard E,
Pouchelet M, Capeau J, Courvalin JC and Buendia B: Nuclear envelope
disorganization in fibroblasts from lipodystrophic patients with
heterozygous R482Q/W mutations in the lamin A/C gene. J Cell Sci.
114:4459–4468. 2001.PubMed/NCBI
|
|
13
|
Goldman RD, Gruenbaum Y, Moir RD, Shumaker
DK and Spann TP: Nuclear lamins: Building blocks of nuclear
architecture. Genes Dev. 16:533–547. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He XX, Chang Y, Meng FY, Wang MY, Xie QH,
Tang F, Li PY, Song YH and Lin JS: MicroRNA-375 targets AEG-1 in
hepatocellular carcinoma and suppresses liver cancer cell growth in
vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He XX, Guo AY, Xu CR, Chang Y, Xiang GY,
Gong J, Dan ZL, Tian DA, Liao JZ and Lin JS: Bioinformatics
analysis identifies miR-221 as a core regulator in hepatocellular
carcinoma and its silencing suppresses tumor properties. Oncol Rep.
32:1200–1210. 2014.PubMed/NCBI
|
|
16
|
Tang W, Zhu J, Su S, Wu W, Liu Q, Su F and
Yu F: MiR-27 as a prognostic marker for breast cancer progression
and patient survival. PLoS One. 7:e517022012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Z, Zhang X, Wang G and Zheng H: Role
of microRNAs in hepatocellular carcinoma. Hepat Mon. 14:e186722014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang YS, Dai Y, Yu XF, Bao SY, Yin YB,
Tang M and Hu CX: Microarray analysis of microRNA expression in
hepatocellular carcinoma and non-tumorous tissues without viral
hepatitis. J Gastroenterol Hepatol. 23:87–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cohen M, Lee KK, Wilson KL and Gruenbaum
Y: Transcriptional repression, apoptosis, human disease and the
functional evolution of the nuclear lamina. Trends Biochem Sci.
26:41–47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan Q, Loya K, Rani B, Möbus S,
Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, et
al: MicroRNA-221 overexpression accelerates hepatocyte
proliferation during liver regeneration. Hepatology. 57:299–310.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pineau P, Volinia S, McJunkin K, Marchio
A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM and
Dejean A: miR-221 overexpression contributes to liver
tumorigenesis. Proc Natl Acad Sci USA. 107:pp. 264–269. 2010;
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Jiang Q, Xia N, Yang H and Hu C:
Decreased expression of microRNA-375 in nonsmall cell lung cancer
and its clinical significance. J Int Med Res. 40:1662–1669. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012. View Article : Google Scholar : PubMed/NCBI
|
